Testing effectiveness (Phase 2)Ended earlyNCT01220258What this trial is testingA Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)Who this might be right forPosterior Blepharoconjunctivitis Merck Sharp & Dohme LLC 29